On another hand recent studies by Dunbar et al., reported that regardless of cancer type, the mutations in genes, such as STK11, KRAS, CTNNB1, KEAP, CDKN2B and MET can predict the high incidence of cancer-associated thrombosis for one year before diagnosis (291, 292). This evidence concerns the gene MET and cancer.